The Mitochondrial-Astrocyte-Neuron Triad Hypothesis in Parkinson’s Disease: A Toxic Feedback Loop of Metabolism, Aggregation, and Oxidative Stress
Abstract
The medical field has spent many years investigating Parkinson's disease (PD), primarily focusing on its main pathogenic feature, dopaminergic neuronal degeneration. Recent studies indicate that PD develops through a complex pathogenic model that links mitochondria to astrocytes and neurons, creating a destructive metabolic loop, a protein aggregation cycle, and oxidative stress. This review examines how mitochondria integrate with astrocytes and neurons in the "triad hypothesis," offering a multifaceted perspective on PD progression. Despite being previously overlooked, we have observed that astrocytic mitochondria play a central role in maintaining neuroprotection and homeostasis. Given that, dysfunctional mitochondria in astrocytes and neurons lead to metabolic failure, compromised glutamate regulation, while also enhancing α-synuclein aggregation, amplifying neuroinflammation, ferroptotic vulnerability and oxidative stress. Henceforth, this report discusses current insights into astrocyte-neuron metabolic coupling, mitochondrial quality control, and lipid redox imbalance, highlighting the role of astrocytic mitochondria as a strong therapeutic strategy. We discuss experimental and translational approaches that aim to restore triad integrity, including mitophagy enhancement, metabolic reprogramming, mitochondrial transfer, and astrocyte-to-neuron reprogramming. By positioning astrocytic mitochondria at the core of PD pathogenesis, this review advocates novel interventions focused on glial metabolic resilience. This integrated approach addresses three major pathogenic axes. It offers promising potential for disease modification and developing effective therapeutics beyond symptomatic dopamine replacement to correct neurodegenerative conditions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971 · see citing works
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · see citing works
Reactive Oxygen Species in Inflammation and Tissue Injury
Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P., & Malik, A. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5149 · Cited by 4,897 · see citing works
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · see citing works
Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313 · see citing works
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,267 · see citing works
Nanotubular Highways for Intercellular Organelle Transport
Rustom, A., Saffrich, R., Markovic, I., Walther, P., & Gerdes, H.-H. (2004) · Science · doi:10.1126/science.1093133 · Cited by 2,038 · see citing works
The pathways of mitophagy for quality control and clearance of mitochondria
Ashrafi, G., & Schwarz, T. L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.81 · Cited by 1,900 · see citing works
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works
Bhatti, J. S., Bhatti, G. K., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.010 · Cited by 1,655 · see citing works
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · see citing works
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446 · see citing works
Transfer of mitochondria from astrocytes to neurons after stroke
Hayakawa, K., Esposito, E., Wang, X., Terasaki, Y., Liu, Y., Xing, C., Ji, X., & Lo, E. H. (2016) · Nature · doi:10.1038/nature18928 · Cited by 1,423 · see citing works
Brain-derived neurotrophic factor and its clinical Implications
Bathina, S., & Das, U. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.56342 · Cited by 1,381 · see citing works
Mitochondrial dynamics in health and disease: mechanisms and potential targets
Chen, W., Zhao, H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01547-9 · Cited by 1,306 · see citing works
Mitochondrial dysfunction: mechanisms and advances in therapy
Yao, Z., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,274 · see citing works
Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115 · see citing works
Glia as architects of central nervous system formation and function
Allen, N. J., & Lyons, D. A. (2018) · Science · doi:10.1126/science.aat0473 · Cited by 1,001 · see citing works
Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877 · see citing works
Glial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote Neurodegeneration
Liu, L., Zhang, K., Sandoval, H., Yamamoto, S., Jaiswal, M., Sanz, E., Li, Z., Hui, J., Graham, B. H., Quintana, A., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.019 · Cited by 876 · see citing works
Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity
Ioannou, M. S., Jackson, J., Sheu, S.-H., Chang, C.-L., Weigel, A. V., Liu, H., Pasolli, H. A., Xu, C. S., Pang, S., Matthies, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.001 · Cited by 760 · see citing works
Do Van, B., Gouel, F., Jonneaux, A., Timmerman, K., Gelé, P., Pétrault, M., Bastide, M., Laloux, C., Moreau, C., Bordet, R., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.011 · Cited by 689 · see citing works
Park, M. W., Cha, H. W., Kim, J., Kim, J. H., Yang, H., Yoon, S., Boonpraman, N., Yi, S. S., Yoo, I. D., & Moon, J.-S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101947 · Cited by 683 · see citing works
The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
Booth, H. D. E., Hirst, W. D., & Wade-Martins, R. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.001 · Cited by 633 · see citing works
Mitochondria at the neuronal presynapse in health and disease
Devine, M. J., & Kittler, J. T. (2018) · Nature reviews. Neuroscience · doi:10.1038/nrn.2017.170 · Cited by 615 · see citing works
Sherer, T., Betarbet, R. S., Stout, A. K., Lund, S. A., Baptista, M. J., Panov, A. V., Cookson, M., & Greenamyre, J. T. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581 · see citing works
Astrocyte-neuron metabolic cooperation shapes brain activity
Bonvento, G., & Bolaños, J. P. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.006 · Cited by 580 · see citing works
Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.02.003 · Cited by 524 · see citing works
Reinhardt, P., Schmid, B., Burbulla, L. F., Schöndorf, D. C., Wagner, L., Glatza, M., Höing, S., Hargus, G., Heck, S. A., Dhingra, A., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.01.008 · Cited by 500 · see citing works
Bayraktar, O. A., Bartels, T., Holmqvist, S., Kleshchevnikov, V., Martirosyan, A., Polioudakis, D., Ben Haim, L., Young, A. M. H., Batiuk, M. Y., Prakash, K., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0602-1 · Cited by 489 · see citing works
Iron and ferroptosis: A still ill‐defined liaison
Doll, S. G., & Conrad, M. (2017) · IUBMB Life · doi:10.1002/iub.1616 · Cited by 472 · see citing works
Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice
Zhou, H., Su, J., Hu, X., Zhou, C., Li, H., Chen, Z., Xiao, Q., Wang, B., Wu, W., Sun, Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.024 · Cited by 437 · see citing works
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Henrich, M. T., Oertel, W. H., Surmeier, D. J., & Geibl, F. F. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00676-7 · Cited by 435 · see citing works
Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes
Abounit, S., Bousset, L., Loria, F., Zhu, S., de Chaumont, F., Pieri, L., Olivo‐Marin, J., Melki, R., & Zurzolo, C. (2016) · The EMBO Journal · doi:10.15252/embj.201593411 · Cited by 414 · see citing works
PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review)
Zhang, Z., Li, Y., Yang, J., Wang, Z., & Du, G. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9375 · Cited by 408 · see citing works
Liu, K., Ji, K., Guo, L., Wu, W., Lu, H., Shan, P., & Yan, C. (2014) · Microvascular Research · doi:10.1016/j.mvr.2014.01.008 · Cited by 391 · see citing works
Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration
Andersen, J. V., Markussen, K. H., Jakobsen, E., Schousboe, A., Waagepetersen, H. S., Rosenberg, P. A., & Aldana, B. I. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108719 · Cited by 375 · see citing works
di Domenico, A., Carola, G., Calatayud, C., Pons-Espinal, M., Muñoz, J. P., Richaud-Patin, Y., Fernandez-Carasa, I., Gut, M., Faella, A., Parameswaran, J., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.011 · Cited by 372 · see citing works
Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
Iovino, L., Tremblay, M., & Civiero, L. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.011 · Cited by 370 · see citing works
Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases
Reddy, P. H., Reddy, T. P., Mańczak, M., Calkins, M. J., Shirendeb, U. P., & Mao, P. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.11.004 · Cited by 366 · see citing works
Cervo, P. R. D. V., Romanov, R. A., Spigolon, G., Masini, D., Martín‐Montañez, E., Toledo, E. M., Manno, G. L., Feyder, M. T., Pifl, C., Ng, Y. H., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3835 · Cited by 357 · see citing works
The history of dopamine and levodopa in the treatment of Parkinson's disease
Fahn, S. (2008) · Movement Disorders · doi:10.1002/mds.22028 · Cited by 344 · see citing works
Mi, Y., Qi, G., Vitali, F., Shang, Y., Raikes, A. C., Wang, T., Jin, Y., Brinton, R. D., Gu, H., & Yin, F. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00756-4 · Cited by 343 · see citing works
Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes
Rostami, J., Holmqvist, S., Lindström, V., Sigvardson, J., Westermark, G. T., Ingelsson, M., Bergström, J., Roybon, L., & Erlandsson, A. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0983-17.2017 · Cited by 339 · see citing works
Levesque, S., Surace, M. J., McDonald, J. D., & Block, M. L. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-105 · Cited by 339 · see citing works
Liu, Y. J., McIntyre, R. L., Janssens, G. E., & Houtkooper, R. H. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111212 · Cited by 334 · see citing works
Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Béard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 309 · see citing works
Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology
Danzer, K. M., Krebs, S. K., Wolff, M., Birk, G., & Hengerer, B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06324.x · Cited by 303 · see citing works
Ganguly, G., Chakrabarti, S., Chatterjee, U., & Saso, L. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s130514 · Cited by 295 · see citing works
Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons
Zhang, L., Yin, J.-C., Yeh, H., Ma, N., Lee, G., Chen, X. A., Wang, Y., Li, L., Chen, L., Jin, P., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.09.012 · Cited by 289 · see citing works
Reactive gliosis in the pathogenesis of CNS diseases
Pekny, M., & Pekna, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.014 · Cited by 276 · see citing works
Mitochondrial quality control in health and in Parkinson’s disease
Eldeeb, M. A., Thomas, R. A., Ragheb, M. A., Fallahi, A., & Fon, E. A. (2022) · Physiological Reviews · doi:10.1152/physrev.00041.2021 · Cited by 276 · see citing works
Astrocytes: a double-edged sword in neurodegenerative diseases
Ding, Z.-B., Song, L., Wang, Q., Kumar, G., Yan, Y.-Q., & Kumar, G. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.306064 · Cited by 244 · see citing works
Metabolic features of the cell danger response
Naviaux, R. K. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.08.006 · Cited by 235 · see citing works
The Role of Astrocytes in the Regulation of Synaptic Plasticity and Memory Formation
Ota, Y., Zanetti, A. T., & Hallock, R. M. (2013) · Neural Plasticity · doi:10.1155/2013/185463 · Cited by 233 · see citing works
Astrocytes and Therapeutics for Parkinson's Disease
Rappold, P. M., & Tieu, K. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.001 · Cited by 228 · see citing works
Glial Development: The Crossroads of Regeneration and Repair in the CNS
Gallo, V., & Deneen, B. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.010 · Cited by 219 · see citing works
Molecular mechanisms of ischemia and glutamate excitotoxicity
Neves, D., Salazar, I. L., Almeida, R. D., & Silva, R. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121814 · Cited by 219 · see citing works
Rose, J., Brian, C., Pappa, A., Panayiotidis, M. I., & Franco, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.536682 · Cited by 196 · see citing works
Cytoskeleton dynamics in axon regeneration
Blanquie, O., & Bradke, F. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.02.024 · Cited by 189 · see citing works
Picca, A., Guerra, F., Calvani, R., Romano, R., Coelho-Júnior, H. J., Bucci, C., & Marzetti, E. (2021) · Biomolecules · doi:10.3390/biom11101508 · Cited by 189 · see citing works
Neuron-Astrocyte Interactions in Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2020) · Cells · doi:10.3390/cells9122623 · Cited by 186 · see citing works
PINK1/Parkin mitophagy and neurodegeneration—what do we really know in vivo?
Whitworth, A. J., & Pallanck, L. J. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.01.016 · Cited by 179 · see citing works
Mitochondrial Biogenesis in Neurons: How and Where
Cardanho‐Ramos, C., & Morais, V. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313059 · Cited by 179 · see citing works
Copas, A. N. M., McComish, S. F., Fletcher, J. M., & Caldwell, M. A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.666737 · Cited by 175 · see citing works
Cho, Y. M., Kim, J. H., Kim, M., Park, S. J., Koh, S. H., Ahn, H. S., Kang, G. H., Lee, J.-B., Park, K. S., & Lee, H. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032778 · Cited by 173 · see citing works
Multifaceted Roles of Tunneling Nanotubes in Intercellular Communication
Marzo, L., Gousset, K., & Zurzolo, C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00072 · Cited by 168 · see citing works
Signaling of Mitochondrial Biogenesis following Oxidant Injury
Rasbach, K. A., & Schnellmann, R. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608009200 · Cited by 168 · see citing works
Mitochondrial biogenesis in the axons of vertebrate peripheral neurons
Amiri, M., & Hollenbeck, P. J. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20668 · Cited by 161 · see citing works
Coenzyme Q 10 as a Possible Treatment for Neurodegenerative Diseases
Beal, M. F. (2002) · Free Radical Research · doi:10.1080/10715760290021315 · Cited by 160 · see citing works
Phytochemicals targeting NF-κB signaling: Potential anti-cancer interventions
Chauhan, A., Islam, A., Prakash, H., & Singh, S. K. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.07.002 · Cited by 160 · see citing works
Vesce, S., Rossi, D., Brambilla, L., & Volterra, A. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82003-4 · Cited by 159 · see citing works
Dieriks, B. V., Park, T. I.-H., Fourie, C., Faull, R. L. M., Dragunow, M., & Curtis, M. A. (2017) · Scientific Reports · doi:10.1038/srep42984 · Cited by 158 · see citing works
Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
Percário, S., Barbosa, A. D. S., Varela, E. L. P., Gomes, A. R. Q., Ferreira, M. E. S., Moreira, T. D. N. A., & Dolabela, M. F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2360872 · Cited by 154 · see citing works
Wu, A., Lee, D., & Xiong, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713398 · Cited by 152 · see citing works
Bido, S., Soria, F. N., Fan, R. Z., Bézard, E., & Tieu, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-07181-0 · Cited by 151 · see citing works
Lin, K.-J., Lin, K.-L., Chen, S., Liou, C., Chuang, Y., Lin, H., & Lin, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215312 · Cited by 141 · see citing works
Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
Martirosyan, A., Ansari, R. A., Pestana, F., Hebestreit, K., Gasparyan, H. A., Aleksanyan, R., Hnatova, S., Poovathingal, S. K., Marneffe, C., Thal, D. R., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00699-0 · Cited by 134 · see citing works
The natural history of parkinson's disease
Poewe, W. H., & Wenning, G. K. (1998) · Annals of Neurology · doi:10.1002/ana.410440703 · Cited by 129 · see citing works
Strategies and prospects of effective neural circuits reconstruction after spinal cord injury
Yang, B., Zhang, F., Cheng, F., Ying, L., Wang, C., Shi, K., Wang, J., Xia, K., Gong, Z., Huang, X., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2620-z · Cited by 128 · see citing works
Schirrmacher, V. (2020) · Biomedicines · doi:10.3390/biomedicines8110526 · Cited by 126 · see citing works
α-Synuclein and Mitochondria: Partners in Crime?
Nakamura, K. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0182-9 · Cited by 123 · see citing works
Albani, D., Polito, L., & Forloni, G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1215 · Cited by 122 · see citing works
Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective
Mulica, P., Grünewald, A., & Pereira, S. L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.668517 · Cited by 121 · see citing works
RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration
Gąsiorowski, K., Brokos, B., Echeverrı́a, V., Barreto, G. E., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0419-4 · Cited by 117 · see citing works
Brekk, O. R., Honey, J. R., Lee, S., Hallett, P. J., & Ole Isacson, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003021117 · Cited by 115 · see citing works
Guo, H., Fan, Z., Wang, S., Ma, L., Wang, J., Yu, D., Zhang, Z., Wu, L., Peng, Z., Liu, W., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02284-y · Cited by 107 · see citing works
Cheng, X.-Y., Biswas, S., Li, J., Mao, C.-J., Chechneva, O. V., Chen, J., Li, K., Li, J., Zhang, J.-R., Liu, C., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00190-6 · Cited by 106 · see citing works
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Peggion, C., Calí, T., & Brini, M. (2024) · Antioxidants · doi:10.3390/antiox13020240 · Cited by 106 · see citing works
Astrocyte-Mediated Neuroinflammation in Neurological Conditions
Zhao, Y., Huang, Y., Cao, Y., & Yang, J. H. (2024) · Biomolecules · doi:10.3390/biom14101204 · Cited by 100 · see citing works
The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration
Hinkle, J. T., Dawson, V. L., & Dawson, T. M. (2019) · Movement Disorders · doi:10.1002/mds.27718 · Cited by 98 · see citing works
Mitochondrial biogenesis is required for axonal growth
Vaarmann, A., Mandel, M., Zeb, A., Warȩski, P., Liiv, J., Kuum, M., Antsov, E., Liiv, M., Cagalinec, M., Choubey, V., et al. (2016) · Development · doi:10.1242/dev.128926 · Cited by 97 · see citing works
Mechanism of metformin regulation in central nervous system: Progression and future perspectives
Cao, G., Gong, T., Du, Y., Wang, Y., Ge, T., & Liu, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113686 · Cited by 97 · see citing works
Mitochondrial dysfunction in astrocytes: A role in Parkinson’s disease?
Bantle, C. M., Hirst, W. D., Weihofen, A., & Shlevkov, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.608026 · Cited by 95 · see citing works
Mitochondria-Targeted Protective Compounds in Parkinson’s and Alzheimer’s Diseases
Fernández‐Moriano, C., González‐Burgos, E., & Gómez-Serranillos, M. P. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/408927 · Cited by 94 · see citing works
Chang, J., Qian, Z., Wang, B., Cao, J., Zhang, S., Jiang, F., Kong, R., Yu, X. H., Cao, X., Yang, L., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01036-6 · Cited by 94 · see citing works
Targeting α‐synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease
Haque, M. E., Akther, M., Azam, S., Kim, I., Lin, Y., Lee, Y., & Choi, D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15684 · Cited by 91 · see citing works
Griffin, J. M., Fackelmeier, B., Fong, D. M., Mouravlev, A., Young, D., & O’Carroll, S. J. (2019) · Gene Therapy · doi:10.1038/s41434-019-0075-6 · Cited by 90 · see citing works
Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
Yi, S., Wang, L., Wang, H., Ho, M. S.-C., & Zhang, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314753 · Cited by 90 · see citing works
Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation
Müller, L., & Benedetto, S. D. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1575022 · Cited by 90 · see citing works
Prevalence and Associated Risk Factors of Cognitive Frailty: A Systematic Review and Meta-Analysis
Zhang, T., Ren, Y., Shen, P., Jiang, S., Yang, Y., Wang, Y., Li, Z., & Yang, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.755926 · Cited by 89 · see citing works
Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
Esteves, A. R., Arduíno, D. M., Silva, D. F., Oliveira, C. R., & Cardoso, S. M. (2011) · Parkinson s Disease · doi:10.4061/2011/693761 · Cited by 89 · see citing works
Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson’s disease
Zhang, X., Xu, S., Hu, Y. H., Liu, Q., Liu, C., Chai, H., Luo, Y., Jin, L., & Li, S. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00453-9 · Cited by 87 · see citing works
Chuang, Y., Chen, S., Hsu, C., Chen, S.-F., Chen, N.-C., & Jou, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040998 · Cited by 81 · see citing works
Guo, X., Liu, R., Jia, M., Wang, Q., & Wu, J. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03923-x · Cited by 79 · see citing works
Advancements and Challenges in Stem Cell Transplantation for Regenerative Medicine
Wei, L., Yan, W., Shah, W., Zhang, Z., Wang, M., Liu, B., Xue, Z., Cao, Y., Hou, X., Zhang, K., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35836 · Cited by 79 · see citing works
Astrocytes as Key Regulators of Neural Signaling in Health and Disease
Won, W., Bhalla, M., Lee, J., & Lee, C. J. (2025) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-112723-035356 · Cited by 74 · see citing works
Castro, C. M., Corciulo, C., Solesio, M. E., Liang, F., Pavlov, E. V., & Cronstein, B. N. (2020) · The FASEB Journal · doi:10.1096/fj.201902459r · Cited by 73 · see citing works
Chakkittukandiyil, A., Sajini, D. V., Karuppaiah, A., & Selvaraj, D. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105325 · Cited by 73 · see citing works
How the brain fights fatty acids’ toxicity
Schönfeld, P., & Reiser, G. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105050 · Cited by 70 · see citing works
The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health
Qiao, L., Yang, G., Wang, P., & Xu, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107434 · Cited by 70 · see citing works
Lo, U., Selvaraj, V., Plane, J. M., Chechneva, O. V., Otsu, K., & Deng, W. (2014) · Scientific Reports · doi:10.1038/srep07405 · Cited by 69 · see citing works
Yang, C., Ling, H., Zhang, M., Yang, Z., Wang, X., Zeng, F., Wang, C., & Feng, J. (2011) · Molecules and Cells · doi:10.1007/s10059-011-1025-3 · Cited by 67 · see citing works
Astrocytes as targets for drug discovery
Gorshkov, K., Aguisanda, F., Thorne, N., & Zheng, W. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.011 · Cited by 62 · see citing works
Jiang, M. Q., Yu, S. P., Wei, Z. Z., Zhong, W., Cao, W., Gu, X., Wu, A., McCrary, M. R., Berglund, K., & Wei, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.612856 · Cited by 59 · see citing works
Guo, Y., Jiang, H., Wang, M., Ma, Y., Zhang, J., & Jing, L. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110723 · Cited by 59 · see citing works
Liu, T., Liu, G., Xu, Y. W., Huang, Y., Zhang, Y., Wu, Y., & Yong-ping, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010553 · Cited by 59 · see citing works
Zhang, H., Zhang, X., Chai, Y., Wang, Y., Zhang, J., & Chen, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584577 · Cited by 59 · see citing works
Functional Significance of the Mitochondrial Membrane Potential
Zorova, L. D., Popkov, V. A., Plotnikov, E. Y., Silachev, D. N., Pevzner, I. B., Jankauskas, S. S., Zorov, S. D., Babenko, V. А., & Zorov, D. B. (2018) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747818010129 · Cited by 58 · see citing works
Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay
Naren, P., Cholkar, A., Kamble, S., Khan, S. S., Srivastava, S., Madan, J., Mehra, N. K., Tiwari, V., Singh, S. B., & Khatri, D. K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220682 · Cited by 57 · see citing works
Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing
Bi, R., Li, Y., Xu, M., Zheng, Q.-Z., Zhang, D.-F., Li, X., Ma, G., Xiang, B., Zhu, X., Zhao, H., et al. (2022) · Innovation (Cambridge (Mass.)) · doi:10.1016/j.xinn.2022.100329 · Cited by 56 · see citing works
Soubannier, V., Maussion, G., Chaineau, M., Sigutova, V., Rouleau, G. A., Durcan, T. M., & Stifani, S. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135028 · Cited by 55 · see citing works
Xu, J., Ji, T., Li, G., Zhang, H., Zheng, Y., Li, M., Ma, J., Li, Y., & Chi, G. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02678-6 · Cited by 54 · see citing works
Core-Shell Structured SiO2@NiFe LDH Composite for Broadband Electromagnetic Wave Absorption
Du, Z., Wang, D., Zhang, X., Yi, Z., Tang, J., Yang, P., Cai, R., Yi, S., Rao, J., & Zhang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010504 · Cited by 54 · see citing works
Microglial dynamics and neuroinflammation in prodromal and early Parkinson’s disease
Mogensen, F. L., Seibler, P., Grünewald, A., & Michelucci, A. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03462-y · Cited by 54 · see citing works
Quiroz‐Baez, R., Hernández‐Ortega, K., & Martínez‐Martínez, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.580030 · Cited by 49 · see citing works
Sun, J.-J., Liu, J., Gao, C.-H., Zheng, J.-P., Zhang, J., Ding, Y., Gong, W., Yang, M.-Y., Li, Z.-P., Wang, Y.-L., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.12.023 · Cited by 45 · see citing works
Regulating astrocyte phenotype by Lcn2 inhibition toward ischemic stroke therapy
Xiao, R., Pan, J., Yang, M., Liu, H., Zhang, A., Guo, X., & Zhou, S. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123102 · Cited by 45 · see citing works
The regulation of mitochondrial dynamics in neurite outgrowth by retinoic acid receptor β signaling
Trigo, D., Goncalves, M. B. C. V., & Corcoran, J. P. T. (2019) · The FASEB Journal · doi:10.1096/fj.201802097r · Cited by 42 · see citing works
Bernhardt, A. M., Longen, S., Trossbach, S. V., Rossi, M., Weckbecker, D., Schmidt, F., Jäck, A., Katzdobler, S., Fietzek, U. M., Weidinger, E., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02853-y · Cited by 42 · see citing works
MAZZIO, E. A., Close, F. T., & Soliman, K. F. A. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12010506 · Cited by 41 · see citing works
Kang, R., Sun, Q., Chen, K., Cao, Q.-T., Liu, C., Liu, K., Ma, Z., Deng, Y. L., Liu, W., & Xu, B. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114207 · Cited by 41 · see citing works
Mohsin, M., Shams, F., Hong Li, A., Alam, A., Xia, C., Fan, L., Cao, Y., Jiang, W., Nasır, A., Khan, S., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03456-w · Cited by 41 · see citing works
Engineering brain-on-a-chip platforms
Servais, B., Mahmoudi, N., Gautam, V., Tong, W., Ibbotson, M. R., Nisbet, D. R., & Collins, D. J. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00184-3 · Cited by 39 · see citing works
Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson’s disease
Chi, X., Yin, S., Sun, Y., Kou, L., Zou, W., Wang, Y., Jin, Z., Wang, T., & Xia, Y. F. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.022 · Cited by 39 · see citing works
Mitochondrial transplantation in brain disorders: Achievements, methods, and challenges
Riou, A., Broeglin, A., & Grimm, A. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105971 · Cited by 39 · see citing works
Dysregulation of cellular membrane homeostasis as a crucial modulator of cancer risk
Erazo‐Oliveras, A., Muñoz‐Vega, M., Salinas, M. L., Wang, X., & Chapkin, R. S. (2022) · FEBS Journal · doi:10.1111/febs.16665 · Cited by 37 · see citing works
van der Vlag, M., Havekes, R., & Heckman, P. R. A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14689 · Cited by 36 · see citing works
Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease
Chen, C., Mossman, E., Malko, P., McDonald, D., Blain, A. P., Bone, L., Erskine, D., Filby, A., Vincent, A. E., Hudson, G., et al. (2022) · Movement Disorders · doi:10.1002/mds.28849 · Cited by 36 · see citing works
Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature
Wadan, A. S., Shaaban, A., El-Sadek, M. Z., Mostafa, S. A., Moshref, A. S., El‐Hussein, A., Ellakwa, D. E., & Mehanny, S. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04014-0 · Cited by 36 · see citing works
You, S., Su, X., Ying, J., Li, S., Qu, Y., & Mu, D. (2022) · Biomolecules · doi:10.3390/biom12081158 · Cited by 35 · see citing works
Primary astrocytic mitochondrial transplantation ameliorates ischemic stroke
Lee, E.-H., Kim, M. K., Ko, S. H., Kim, C., Lee, M., & Park, C. (2023) · BMB Reports · doi:10.5483/bmbrep.2022-0108 · Cited by 35 · see citing works
Glycerophospholipid dysregulation after traumatic brain injury
Sarkar, C., & Lipinski, M. M. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105701 · Cited by 35 · see citing works
Liu, Z., Liu, K., Liu, Z., Cong, L., Lei, M., Ma, Z., Li, J., Deng, Y. L., Liu, W., & Xu, B. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112213 · Cited by 34 · see citing works
Soni, P., Kaidery, N. A., Sharma, S. M., Gazaryan, I. G., Nikulin, S. V., Hushpulian, D. M., & Thomas, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1390798 · Cited by 34 · see citing works
Cao, J., Dong, L., Luo, J., Zeng, F., Hong, Z., Liu, Y., Zhao, Y., Xia, Z., Zuo, D., Xu, L., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5524705 · Cited by 32 · see citing works
p38 MAPK Activity Is Required to Prevent Hyperactivation of NLRP3 Inflammasome
Shin, J. N., Rao, L., Sha, Y., Fattah, E. A., Hyser, J. M., & Eissa, N. T. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000416 · Cited by 30 · see citing works
Progress of Astrocyte-Neuron Crosstalk in Central Nervous System Diseases
Zhang, Y., Wang, Z., Xu, F., Liu, Z., Zhao, Y., Yang, L. Z., & Fang, W. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04241-6 · Cited by 28 · see citing works
Vasquez, V., Kodavati, M. M., Mitra, J., Vedula, I., Hamilton, D. J., Garruto, R. M., Rao, K. S. J., & Hegde, M. L. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07258-5 · Cited by 27 · see citing works
How cytoskeletal proteins regulate mitochondrial energetics in cell physiology and diseases
Solomon, T., Rajendran, M., Rostovtseva, T. K., & Hool, L. C. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0324 · Cited by 24 · see citing works
Intercellular transmission of alpha-synuclein
Wu, S., & Schekman, R. W. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1470171 · Cited by 24 · see citing works
Mitochondrial Dysfunction of Astrocytes Mediates Lipid Accumulation in Temporal Lobe Epilepsy
Su, Y., Tang, M., & Wang, M. (2023) · Aging and Disease · doi:10.14336/ad.2023.0624 · Cited by 23 · see citing works
Barakat, R., & Redzic, Z. B. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0002-1 · Cited by 22 · see citing works
Astrocyte heterogeneity in ischemic stroke: Molecular mechanisms and therapeutic targets
Li, D., Huo, X., Shen, L., Qian, M., Wang, J., Mao, S., Chen, W., Li, R. Q., Zhu, T., Zhang, B., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106885 · Cited by 22 · see citing works
Mechanisms of NLRP3 activation and pathology during neurodegeneration
Jose, S., Groves, N. J., Roper, K. E., & Gordon, R. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106273 · Cited by 21 · see citing works
Ravenhill, S. M., Evans, A. H., & Crewther, S. G. (2023) · Antioxidants · doi:10.3390/antiox12051117 · Cited by 21 · see citing works
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1
Freye, E. C. K. (1997) · Journal of Neurosurgical Anesthesiology · doi:10.1097/00008506-199710000-00016 · Cited by 20 · see citing works
Chen, G., Tang, H., Yang, Y., Zhou, L., Wang, Q., Hu, D., & Li, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40146 · Cited by 20 · see citing works
Breakdown and repair of metabolism in the aging brain
Shichkova, P., Coggan, J. S., Kanari, L., Boci, E., Favreau, C., Antonel, S., Keller, D. X., & Markram, H. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1441297 · Cited by 20 · see citing works
Non-Cell-Autonomous Neurotoxicity in Parkinson’s Disease Mediated by Astroglial α-Synuclein
Chai, M., & Kohyama, J. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.011 · Cited by 19 · see citing works
The Role of Astrocytic Mitochondria in the Pathogenesis of Brain Ischemia
Zhang, L., Hu, Y., Liu, X., Wang, X., Li, S., Zhang, J., Xian, X., Li, W., & Zhang, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03714-z · Cited by 18 · see citing works
Zhong, H., Liu, H., & Fu, Q. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665333926240927074528 · Cited by 18 · see citing works
Martino, R. D., Sisalli, M. J., Sirabella, R., Notte, S. D., Borzacchiello, D., Feliciello, A., Annunziato, L., & Scorziello, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158177 · Cited by 17 · see citing works
Guan, Y., Wang, R., Li, X., Zou, H., Yu, W., Liang, Z., Li, L., Chen, L., Zhou, L., & Chen, Z. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111971 · Cited by 17 · see citing works
Glial cell crosstalk in Parkinson's disease: Mechanisms, implications, and therapeutic strategies
Wang, N., Xiao, X., Chen, Z., Xu, K., Cao, X., Kou, D., & Zeng, J. (2025) · Fundamental Research · doi:10.1016/j.fmre.2024.12.023 · Cited by 17 · see citing works
Gupta, R., & Gupta, N. (2021) · Springer eBooks · doi:10.1007/978-981-16-0723-3_12 · Cited by 16 · see citing works
Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
Hu, L., Wang, W., Chen, X., Bai, G., Ma, L., Yang, X., Shu, Q., & Li, X. (2024) · Brain‐X · doi:10.1002/brx2.52 · Cited by 16 · see citing works
Phospholipid and glycerolipid metabolism as potential diagnostic biomarkers for acute pancreatitis
Shi, C., Liu, S., Zheng, M., Yan, F., Xu, D., Wang, W. T., & Chen, J. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02217-7 · Cited by 15 · see citing works
Wang, F., Liu, X., Chen, M., Xu, X., Yang, Y., Xu, Q., Zhu, H., Xu, X., Pouladi, M. A., & Xu, X. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.034 · Cited by 15 · see citing works
Dienel, G. A., Schousboe, A., McKenna, M. C., & Rothman, D. L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15812 · Cited by 14 · see citing works
Huang, L., Zeng, F., Wei, H., Su, T., Su, Y., Lin, Y., Niu, Q., & Xu, Q. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.032 · Cited by 13 · see citing works
Disease progression subtypes of Parkinson’s disease based on milestone events
Chen, S., Wang, M., Shao, J.-Y., Yang, H., Zhang, H., & Zhang, J. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12645-1 · Cited by 12 · see citing works
Mitochondria and astrocyte reactivity: Key mechanism behind neuronal injury
Cassina, P., Miquel, E., Palma, L. M., & Cassina, A. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.058 · Cited by 12 · see citing works
Setiawan, E., Purwanto, B., Wasita, B., et al. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104529 · Cited by 11 · see citing works
The function of astrocytes in cerebral infarction and potential therapeutic approaches
Beylerli, O., Фанилевич, Г. И., Beilerli, A., Ilyasova, T., Shi, H., & Sufianov, A. A. (2024) · Brain Hemorrhages · doi:10.1016/j.hest.2024.03.003 · Cited by 11 · see citing works
Astrocyte mitochondria: Potential therapeutic targets for epilepsy
Chen, L., Yang, W., Yang, F., Xu, T., Yu, Y., Wu, Q., & Han, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29950 · Cited by 11 · see citing works
Pro‐ and Anti‐Inflammatory Role of Complement in Cancer
Pal, P., Wahi, P., Sahu, A., & Lal, G. (2025) · European Journal of Immunology · doi:10.1002/eji.202451767 · Cited by 11 · see citing works
Connecting the dots: Mitochondrial transfer in immunity, inflammation, and cancer
Artusa, V., Luca, L. D., Clerici, M., & Trabattoni, D. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.106992 · Cited by 10 · see citing works
Tichauer, J. E., Lira, M., Cerpa, W. F., Orellana, J. A., Sáez, J. C., & Rovegno, M. (2024) · Biological Research · doi:10.1186/s40659-024-00519-9 · Cited by 7 · see citing works
Principles of mitochondrial fusion and fission cycle in neurons
Kaasik, A. (2015) · SpringerPlus · doi:10.1186/2193-1801-4-s1-l34 · Cited by 5 · see citing works
New insights on the regulators and inhibitors of RhoA-ROCK signalling in Parkinson’s disease
Ravichandran, N., Iyer, M., Uvarajan, D., Kirola, L., Kumra, S. M., Babu, H. W. S., HariKrishnaReddy, D., Vellingiri, B., & Narayanasamy, A. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-024-01500-x · Cited by 5 · see citing works
Zhou, H., Dai, J., Li, D., Wang, L., Ye, M., Hu, X., LoTurco, J. J., Hu, J., & Sun, W. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.006 · Cited by 5 · see citing works
Conjunctival impression cytology and tear film analysis in early-stage Parkinson’s disease
Tezcan, A., Oltulu, R., Oltulu, P., Gündoğan, A. O., & Belviranlı, S. (2025) · European Journal of Ophthalmology · doi:10.1177/11206721251330472 · Cited by 3 · see citing works
Zhou, H., Dai, J., Li, D., Wang, L., Ye, M., Hu, X., LoTurco, J. J., Hu, J., & Sun, W. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.05.015 · Cited by 3 · see citing works
Targeting mitochondrial metabolism to overcome hormone resistance in breast cancer
Neamah, A. S., Lafta, F. M., & Wadan, A. S. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04487-z · Cited by 3 · see citing works
Köhler, P., & Tielens, L. (2016) · Springer eBooks · doi:10.1007/978-3-662-43978-4_1057 · Cited by 1 · see citing works
Sun, S., Wang, Q., Zhang, Z., Huang, J., Huang, Y., Han, J., Du, Y.-H., & Zhang, X. (2025) · Research Square · doi:10.21203/rs.3.rs-5653722/v1 · Cited by 1 · see citing works
Su, Y., Li, S., Nie, G., Zhao, R., Ma, G., Zhao, Y., Wang, P., & Liu, C. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.05.008 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- Zade A (2025) Glial metabolism in neurodegenerative disorders: bridging pathophysiology and therapeutics. J Internal Med Pharmacol 2(01):01–12
- Bantle CM, Hirst WD, Weihofen A, Shlevkov E (2021) Mitochondrial dysfunction in astrocytes: A role in Parkinson’s disease? Front Cell Dev Biol 8:608026 · DOI · Paper page
- Bhatti JS, Bhatti GK, Reddy PH (2017) Mitochondrial dysfunction and oxidative stress in metabolic disorders — a step towards mitochondria-based therapeutic strategies. Biochim Biophys Acta (BBA) Mol Basis of Dis 1863(5):1066–1077. https://doi.org/10.1016/j.bbadis.2016.11.010 · DOI · Paper page
- Iovino L, Tremblay ME, Civiero L (2020) Glutamate-induced excitotoxicity in Parkinson’s disease: the role of glial cells. J Pharmacol Sci 144(3):151–164. https://doi.org/10.1016/j.jphs.2020.07.011 · DOI
- Henrich MT, Oertel WH, Surmeier DJ, Geibl FF (2023) Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential. Mol Neurodegener 18(1):83. https://doi.org/10.1186/s13024-023-00676-7 · DOI
- Bantle CM, Hirst WD, Weihofen A, Shlevkov E (2020) Mitochondrial dysfunction in astrocytes: a role in Parkinson’s disease? Front Cell Dev Biol 8:608026. https://doi.org/10.3389/fcell.2020.608026 · DOI · Paper page
Cited by
Still being checked.
- Authors
- Walecha, V., & Luthra, P. M.
- Affiliations
- University of Delhi (IN)
- Corresponding author
- Luthra, Pratibha M.
- ORCID
- Luthra, Pratibha M.
- Venue
- Neurochemical Research
- Published
- 2025-10
- Volume
- 50
- Issue
- 5
- Pages
- 317-317
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W4414809925
- Semantic Scholar
- ba5754ac2d9ca8fa965d407e22310b19a75842ca
- Cited by
- 12
- References
- 188
- Citations by year
- 2026: 11 · 2025: 1
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, mitochondrial quality control, mitophagy, alpha-synuclein aggregation, oxidative stress, ferroptosis, neuroinflammation, glutamate regulation, metabolic coupling, metabolic reprogramming, mitochondrial transfer, dopaminergic neuron loss, neuroprotection
- MeSH terms
- Animals, Astrocytes, Humans, Mitochondria, Neurons, Parkinson Disease, Oxidative Stress, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review